Comparison Chart FibroBiologics, Inc.

Stocks

FBLG

US31573L2043

Biotechnology & Medical Research

Market Closed - Nasdaq 16:00:00 2026-10-30 EDT			5-day change	1st Jan Change
0.9300 ^USD	+0.20%		-2.11%	-79.32%

10-14	Fibrobiologics, Inc. Announces Australian Patent Accepted for Cellular Blend for the Regeneration of Chondrocytes and Cartilage Cells in Degenerated Spinal Discs	CI
10-07	FibroBiologics, Inc. announced that it has received $1.02 million in funding from Peak One Investments, LLC	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	FIBROBIOLOGICS, INC.	Bio Therapeutic Drugs	+0.20%	-2.11%	-79.32%	-88.28%	-	6.47M	-	-	-